Concepedia

Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis

Paulo D’Amora, Ismael Dale C. G. Silva, Krishnansu S. Tewari, Robert E. Bristow, Fabio Cappuccini, Steven S. Evans, Márcia Batista Salzgeber, Paula J. Addis-Bernard, Anton M. Palma, Dirce Maria Lobo Marchioni,

Gynecologic Oncology · 2021 · 27 citations · 31 references

DOIFull text

Open access

Concepts

References

31

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

, , +14

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

, , +16

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

A. Hilary Calvert, David R. Newell, Lindsey Gumbrell et al. · Journal of Clinical Oncology · 1989 · 1.9K citations

, , +17

Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst

Jianguo Xia, David S. Wishart · Nature Protocols · 2011 · 1.4K citations

, , +16

Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs

Sydney E. Salmon, Anne W. Hamburger, B Soehnlen et al. · New England Journal of Medicine · 1978 · 974 citations

, , +16